WNT5A in tumor development and progression: A comprehensive review
Open Access
- 9 September 2022
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 155, 113599
Abstract
No abstract availableKeywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (303405/2018-0)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/21801-2)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/25247-5)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2021/05320-0)
This publication has 89 references indexed in Scilit:
- WNT5A Encodes Two Isoforms with Distinct Functions in CancersPLOS ONE, 2013
- Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cellsBMC Cancer, 2013
- Wnt5a Is Associated with Cigarette Smoke-Related Lung Carcinogenesis via Protein Kinase CPLOS ONE, 2013
- Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expressionBMC Cancer, 2012
- Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low‐grade prostate cancerCancer Medicine, 2012
- Wnt5a Is Strongly Expressed at the Leading Edge in Non-Melanoma Skin Cancer, Forming Active Gradients, while Canonical Wnt Signalling Is RepressedPLOS ONE, 2012
- Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular SenescenceCancer Research, 2011
- A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasionProceedings of the National Academy of Sciences, 2009
- Phenylmethimazole Decreases Toll-Like Receptor 3 and Noncanonical Wnt5a Expression in Pancreatic Cancer and Melanoma Together with Tumor Cell Growth and MigrationClinical Cancer Research, 2009
- Detecting PKC Phosphorylation as Part of the Wnt/Calcium Pathway in Cutaneous Melanoma2008